Your account is not claimed yet. You can sign up with ORCID to claim your account.

Mohamed Abou-El-Enein

Scopus Author ID ResearcherID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 7

Top Venues

Nature reviews. Clinical oncology

Cancer gene therapy

Allergy

Stem cells translational medicine

Harvard Medical School

Université de Strasbourg (MSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Harvard Medical School Dec 15o 2014

United States

Teaching Assistant in Clinical Research :: Spaulding Rehabilitation Hospital

Education History

Université de Strasbourg May 10o 2012 - Nov 15o 2014

France

MSC :: Faculty of Pharmacy

Publications

Jonas Kath, Weijie Du, Stefania Martini, Magdi Elsallab, Clemens Franke, Laura Marie Hartmann, Vanessa Drosdek, Viktor Glaser, Maik Stein, Michael Schmueck-Henneresse, Petra Reinke, Hans-Dieter Volk, Mohamed Abou-El-Enein, Dimitrios Laurin Wagner
CAR NK-92 cell-mediated depletion of residual TCR+ cells for ultra-pure allogeneic TCR-deleted CAR T-cell products. Blood advances (2023)
Magdi Elsallab, Moataz Ellithi, Susanne Hempel, Hisham Abdel-Azim, Mohamed Abou-El-Enein
Long-term response to autologous anti-CD19 chimeric antigen receptor T cells in relapsed or refractory B cell acute lymphoblastic leukemia: a systematic review and meta-analysis. Cancer gene therapy (2023)
Magdi Elsallab, Moataz Ellithi, Susanne Hempel, Hisham Abdel-Azim, Mohamed Abou-El-Enein
Long-term response to autologous anti-CD19 chimeric antigen receptor T cells in relapsed or refractory B cell acute lymphoblastic leukemia: a systematic review and meta-analysis. Cancer gene therapy (2023)
Leila Amini, Sara K Silbert, Shannon L Maude, Loretta J Nastoupil, Carlos Almeida Ramos, Renier J Brentjens, Craig S Sauter, Nirali N Shah, Mohamed Abou-El-Enein
Preparing for CAR T cell therapy: patient selection, bridging therapies and lymphodepletion. Nature reviews. Clinical oncology 19 (5) (2022)
Christian L Flugel, Robbie G Majzner, Giedre Krenciute, Gianpietro Dotti, Stanley R Riddell, Dimitrios Laurin Wagner, Mohamed Abou-El-Enein
Overcoming on-target, off-tumour toxicity of CAR T cell therapy for solid tumours. Nature reviews. Clinical oncology (2022)
Constantin J Thieme, Mohamed Abou-El-Enein, Enrico Fritsche, Moritz Anft, Krystallenia Paniskaki, Sarah Skrzypczyk, Adrian Doevelaar, Magdi Elsallab, Nicola Brindle, Arturo Blazquez-Navarro, Felix S Seibert, Toni L Meister, Stephanie Pfaender, Eike Steinmann, Oliver Witzke, Timm H Westhoff, Ulrik Stervbo, Guido Heine, Toralf Roch, Nina Babel
Detection of SARS-CoV-2-specific memory B cells to delineate long-term COVID-19 immunity. Allergy 76 (8) (2021)
Gerhard Bauer, Magdi Elsallab, Mohamed Abou-El-Enein
Concise Review: A Comprehensive Analysis of Reported Adverse Events in Patients Receiving Unproven Stem Cell-Based Interventions. Stem cells translational medicine 7 (9) (2018)

Mohamed Abou-El-Enein.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Mohamed Abou-El-Enein